MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biotechnology _ Gene Editing, CRISPR, Etc.
HORIZON DISCOVERY GROUP
Attachments
Inspired Cell Solutions
Parents
*Architects: Biotechnology _ Gene Editing, CRISPR, Etc.
Companies: Acquired_(M&A)
Finance & Acquisitions: PerkinElmer
Children
2016: Fulcrum, which is developing therapies for Fragile X syndrome and a form of muscular dystrophy, was launched earlier this year with $55 million in financing from Third Rock Ventures LLC, a founding investor in Editas Medicine.
2020: PerkinElmer Adds Cell Engineering Tools with $383M Horizon Acquisition
Jumps
Fulcrum Therapeutics, Inc. (NASDAQ: FULC)*